Testing effectiveness (Phase 2)Ended earlyNCT03795233What this trial is testingFecal Microbiota Transplant for Primary CDIWho this might be right forClostridium Difficile Infection Boston Medical Center 5
Early research (Phase 1)Study completedNCT01551004What this trial is testingPhase I Trial of a Single Dose of CRS3123Who this might be right forClostridium Difficile Colitis National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05805826What this trial is testingTo Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy AdultsWho this might be right forClostridoides Difficile Associated Disease Pfizer 936
Testing effectiveness (Phase 2)Study completedNCT01232595What this trial is testingSafety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile InfectionsWho this might be right forModerate Clostridium Difficile Infection Novartis Pharmaceuticals 109
Post-approval studies (Phase 4)Study completedNCT03466502What this trial is testingOral Vancomycin to Prevent Recurrent C Difficile Infection With AntibioticsWho this might be right forClostridium Difficile Infection University of Nevada, Reno 104
Large-scale testing (Phase 3)Ended earlyNCT01887912What this trial is testingStudy of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile InfectionWho this might be right forClostridium Difficile Infection Sanofi Pasteur, a Sanofi Company 9,302
Not applicableWithdrawnNCT01842347What this trial is testingTreatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT)Who this might be right forClostridium Difficile Infection Medical College of Wisconsin
Not applicableUnknownNCT03586206What this trial is testingRelationship Between C. Difficile Toxins' Serum Level With C. Difficile InfectionWho this might be right forClostridium DifficileClostridium Difficile Infection Roma Tre University 45
Post-approval studies (Phase 4)WithdrawnNCT04241744What this trial is testingProspective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDIWho this might be right forCDI Creighton University
Testing effectiveness (Phase 2)Ended earlyNCT03617445What this trial is testingFecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsWho this might be right forClostridium Difficile Infection Recurrence University of Wisconsin, Madison 3
Large-scale testing (Phase 3)Study completedNCT02254811What this trial is testingFMT Delivered by Capsule Versus Colonoscopy for Recurrent C. DiffWho this might be right forEnterocolitis Clostridium Difficile Recurrent University of Alberta 116
Testing effectiveness (Phase 2)Looking for participantsNCT04305769What this trial is testingAlanyl-glutamine Supplementation for C. Difficile Treatment (ACT)Who this might be right forClostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more University of Virginia 260
Not applicableStudy completedNCT05703477What this trial is testingThe Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile InfectionWho this might be right forClostridium Difficile InfectionFecal Microbiota Transplantation Shanghai 10th People's Hospital 60
Not applicableStudy completedNCT01930032What this trial is testingPathogenic Mechanisms in C Diff Infection and ColitisWho this might be right forClostridium Difficile Infection Beth Israel Deaconess Medical Center 24
Early research (Phase 1)Study completedNCT02830542What this trial is testingSER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent RecurrenceWho this might be right forClostridium Difficile Infection Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02299570What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile InfectionWho this might be right forEnterocolitis Clostridium Difficile Recurrent Rebiotix Inc. 150
Not applicableStudy completedNCT04014608What this trial is testingProtocol for Admission Toxigenic C. Difficile SurveillanceWho this might be right forClostridium Difficile Infection Endeavor Health 148,549
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461What this trial is testingA Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.Who this might be right forIrritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more PharmaPlanter Technologies Inc 63
Large-scale testing (Phase 3)Ended earlyNCT00466635What this trial is testingAssess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaWho this might be right forEnterocolitis, PseudomembranousDiarrheaClostridium Difficile Genzyme, a Sanofi Company 65
Testing effectiveness (Phase 2)Study completedNCT01230957What this trial is testingStudy of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in AdultsWho this might be right forClostridium Difficile InfectionDiarrhea Sanofi Pasteur, a Sanofi Company 650